ibrutinib
janssen,abbvie
['cll']
 must have been a great talk and discussion! well- conducted trial for sure. i wonder if newer, less toxic btk inhibitors can do better? #cllsm
Assistant Professor, UM Sylvester Comprehensive Cancer Center. Physician scientist studying the role of nuclear export and splicing in hematologic cancers.